Harmony Biosciences Holdings Inc HRMY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
43.64UNCH (UNCH)
Volume
8,384
Close
43.64quote price arrow down-0.28 (-0.64%)
Volume
373,748
52 week range
31.54 - 57.13
Loading...
  • Open43.50
  • Day High43.65
  • Day Low42.30
  • Prev Close43.92
  • 52 Week High57.13
  • 52 Week High Date07/07/22
  • 52 Week Low31.54
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap2.582B
  • Shares Out59.16M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change2.35

KEY STATS

  • Open43.50
  • Day High43.65
  • Day Low42.30
  • Prev Close43.92
  • 52 Week High57.13
  • 52 Week High Date07/07/22
  • 52 Week Low31.54
  • 52 Week Low Date01/24/22
  • Market Cap2.582B
  • Shares Out59.16M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change2.35

RATIOS/PROFITABILITY

  • EPS (TTM)0.95
  • P/E (TTM)45.95
  • Fwd P/E (NTM)23.63
  • EBITDA (TTM)131.042M
  • ROE (TTM)31.15%
  • Revenue (TTM)364.29M
  • Gross Margin (TTM)81.87%
  • Net Margin (TTM)15.95%
  • Debt To Equity (MRQ)77.80%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harmony Biosciences Holdings Inc

 

Profile

MORE
Harmony Biosciences Holdings, Inc. is a holding company. The Company’s operations are conducted through its wholly owned subsidiary, Harmony Biosciences, LLC (Harmony). The Company is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with neurological disorders. The Company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action (MOA) specifically designed to increase histamine signaling in the...
Jeffrey Aronin
Non-Executive Chairman of the Board
John Jacobs
President, Chief Executive Officer, Director
Sandip Kapadia CPA
Chief Financial Officer
Address
630 W Germantown Pike, Suite 215
Plymouth Meeting, PA
19462
United States

Top Peers

SYMBOLLASTCHG%CHG
CORT
Corcept Therapeutics Inc
25.54-0.50-1.92%
PCRX
Pacira Biosciences Inc
54.24+0.10+0.18%
IRWD
Ironwood Pharmaceuticals Inc
10.37-0.26-2.45%
TVTX
Travere Therapeutics Inc
24.64-0.65-2.57%
SUPN
Supernus Pharmaceuticals Inc
33.28-0.13-0.39%